Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial)

TD Pinkney, M Calvert, DC Bartlett, A Gheorghe… - Bmj, 2013 - bmj.com
Objective To determine the clinical effectiveness of wound edge protection devices in
reducing surgical site infection after abdominal surgery. Design Multicentre observer blinded …

Systematic review of the clinical effectiveness of wound-edge protection devices in reducing surgical site infection in patients undergoing open abdominal surgery

A Gheorghe, M Calvert, TD Pinkney, BR Fletcher… - Annals of …, 2012 - journals.lww.com
Objective: Assess the existing evidence on the clinical effectiveness of wound-edge
protection devices (WEPDs) in reducing the surgical site infection (SSI) rate in patients …

[HTML][HTML] Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience

RH Bhogal, J Hodson, DC Bartlett, CJ Weston… - PloS one, 2011 - journals.plos.org
Successful and consistent isolation of primary human hepatocytes remains a challenge for
both cell-based therapeutics/transplantation and laboratory research. Several centres …

Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function

DC Bartlett, C Lloyd, PJ McKiernan… - Journal of inherited …, 2014 - Springer
Abstract Background Tyrosinaemia type 1 (HT1) is a rare disorder of tyrosine metabolism
leading to liver failure and hepatocellular carcinoma. Treatment previously consisted of …

Utilization of declined liver grafts yields comparable transplant outcomes and previous decline should not be a deterrent to graft use

F Marcon, A Schlegel, DC Bartlett, M Kalisvaart… - …, 2018 - journals.lww.com
Background In the United Kingdom, up to 20% of liver graft offers are not used for
transplantation, and the reasons for graft refusal are multifactorial and not consistent among …

The impact of timing of cholecystectomy following gallstone pancreatitis

M Johnstone, P Marriott, TJ Royle, CE Richardson… - the surgeon, 2014 - Elsevier
Introduction Current guidelines for the management of acute gallstone pancreatitis
recommend cholecystectomy as definitive treatment during primary admission or within 2 …

Human mesenchymal stem cells are recruited to injured liver in a β1-integrin and CD44 dependent manner

V Aldridge, A Garg, N Davies, DC Bartlett, J Youster… - Hepatology, 2012 - journals.lww.com
Human bone marrow mesenchymal stem cells (hMSCs) have shown benefit in clinical trials
of patients with liver disease. Efficient delivery of cells to target organs is critical to improving …

[HTML][HTML] How to set up and manage a trainee-led research collaborative

G Dowswell, DC Bartlett, K Futaba, L Whisker… - BMC medical …, 2014 - Springer
Background Ensuring that doctors in training acquire sufficient knowledge, experience and
understanding of medical research is a universal and longstanding issue which has been …

[HTML][HTML] Incidental gallbladder cancer diagnosis confers survival advantage irrespective of tumour stage and characteristics

M Alarabiyat, SS Raza, J Isaac, D Mirza… - World journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Incidental gallbladder cancer (IGBC) represents 50%-60% of gallbladder
cancer cases. Data are conflicting on the role of IGBC diagnosis in oncological outcomes …

[PDF][PDF] The metabolism and elimination of cimetidine, a histamine H2-receptor antagonist, in the rat, dog, and man.

DC Taylor, PR Cresswell, DC Bartlett - Drug Metabolism and Disposition, 1978 - Citeseer
The excretion and metabolism of cimetidine, a histamine H2-receptor antagonist, was
compared in the rat, dog, and man at different dose levels; a marked similarity between the …